Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.

A recent U-M study uncovers a pathway utilized during normal wound healing that has the potential to reverse idiopathic pulmonary fibrosis.

An updated rat reference provides more accuracy for research; could help researchers using rat models for the study of DNA, RNA, evolution, or genes linked to disease risks

Known as the Health Equity Literature Archive, Chelsea Fisk’s goal was to cultivate empathy and understanding for people from different backgrounds and diverse identities by providing employees with access to diverse literature. The innovative pilot led by clinical researcher Chelsea Fisk served as a form of DEI education that was free to use, self-paced and barrier-free.

A new study links two autism-associated genes together for the first time, potentially revealing a mechanism behind brain changes seen in people with autism.

Experience gave him a new appreciation for interprofessional patient care

A physician invents a creative approach for medical students in diabetic care.

The tool, which is free to use, includes photography, videography and virtual reality learning resources from anatomical donors, along with comprehensive lab manuals and interactive files with click-to-reveal testing capabilities.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

In his practice as a podiatrist, surgeon, and wound care specialist, Alton R. Johnson Jr., D.P.M., sees a high percentage of patients with diabetes who seek care for things such as neuropathy, vascular complications, or chronic wounds associated with the diabetic foot.

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.